Dynavax Technologies (DVAX) News Today $13.05 +0.04 (+0.31%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$12.92 -0.13 (-0.96%) As of 01/31/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Dynavax adds two new directors, announces board retirementsJanuary 30 at 1:59 AM | msn.com77,524 Shares in Dynavax Technologies Co. (NASDAQ:DVAX) Bought by SG Americas Securities LLCSG Americas Securities LLC purchased a new stake in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 77,524 shares of the biopharmaceutical compJanuary 29 at 3:15 AM | marketbeat.comDynavax adds new directors, plans board declassificationJanuary 27, 2025 | msn.comDynavax Technologies Corp (DVAX) Announces Strategic Board ChangesJanuary 27, 2025 | gurufocus.comDynavax Advances Board Refreshment ProgramJanuary 27, 2025 | prnewswire.comEquities Analysts Issue Forecasts for DVAX Q1 EarningsDynavax Technologies Co. (NASDAQ:DVAX - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Dynavax Technologies in a note issued to investors on Tuesday, January 14th. HC Wainwright analyst E. White anticipates that the biopharmaceutical company wilJanuary 17, 2025 | marketbeat.comBrokers Issue Forecasts for DVAX Q2 EarningsDynavax Technologies Co. (NASDAQ:DVAX - Free Report) - Investment analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Dynavax Technologies in a research report issued on Tuesday, January 14th. HC Wainwright analyst E. White expects that the biopharmaceuticalJanuary 16, 2025 | marketbeat.comWilliam Blair Analysts Increase Earnings Estimates for DVAXDynavax Technologies Co. (NASDAQ:DVAX - Free Report) - William Blair increased their Q4 2024 earnings per share estimates for Dynavax Technologies in a research note issued on Monday, January 13th. William Blair analyst M. Phipps now expects that the biopharmaceutical company will post earnings oJanuary 16, 2025 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Raised to Buy at StockNews.comStockNews.com upgraded Dynavax Technologies from a "hold" rating to a "buy" rating in a report on Tuesday.January 14, 2025 | marketbeat.comDynavax’s Strong Growth Potential Driven by Heplisav-B Sales and Strategic Market PositioningJanuary 14, 2025 | markets.businessinsider.comDynavax price target raised to $31 from $29 at H.C. WainwrightJanuary 14, 2025 | markets.businessinsider.comDynavax Technologies (NASDAQ:DVAX) Stock Price Expected to Rise, HC Wainwright Analyst SaysHC Wainwright lifted their target price on shares of Dynavax Technologies from $29.00 to $31.00 and gave the company a "buy" rating in a report on Tuesday.January 14, 2025 | marketbeat.comDynavax Technologies: Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial HighlightsJanuary 14, 2025 | finanznachrichten.deStrong Market Position and Growth Potential Drive Buy Rating for DynavaxJanuary 14, 2025 | markets.businessinsider.comDynavax (DVAX) Receives a Buy from JMP SecuritiesJanuary 14, 2025 | markets.businessinsider.comDynavax Technologies Corp (DVAX) Reports Strong 2024 Financial PerformanceJanuary 13, 2025 | gurufocus.comDynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial HighlightsJanuary 13, 2025 | prnewswire.comDynavax Technologies (NASDAQ:DVAX) Stock Crosses Above Two Hundred Day Moving Average - What's Next?Dynavax Technologies (NASDAQ:DVAX) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?January 10, 2025 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Share Price Crosses Above 200-Day Moving Average - Here's What HappenedDynavax Technologies (NASDAQ:DVAX) Share Price Crosses Above 200-Day Moving Average - Time to Sell?January 10, 2025 | marketbeat.comNordea Investment Management AB Acquires 232,690 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Nordea Investment Management AB boosted its stake in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 42.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 777,816 shares of the biopharmaceutical company's stocJanuary 10, 2025 | marketbeat.comImplied Volatility Surging for Dynavax Technologies (DVAX) Stock OptionsJanuary 3, 2025 | msn.comPrincipal Financial Group Inc. Reduces Holdings in Dynavax Technologies Co. (NASDAQ:DVAX)Principal Financial Group Inc. lowered its stake in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 24.3% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 577,727 shares of the biopharmaceutical company's stock afteJanuary 2, 2025 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Short Interest Down 6.3% in DecemberDynavax Technologies Co. (NASDAQ:DVAX - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 16,780,000 shares, a decline of 6.3% from the November 30th total of 17,900,000 shares. Based on an average daily trading volume, of 2,100,000 shares, the days-to-cover ratio is presently 8.0 days.December 31, 2024 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Position Lessened by Geode Capital Management LLCGeode Capital Management LLC reduced its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 2.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,999,935 shares of the biopharmaceDecember 26, 2024 | marketbeat.comBarclays PLC Has $3.37 Million Stake in Dynavax Technologies Co. (NASDAQ:DVAX)Barclays PLC raised its holdings in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 137.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 302,572 shares of the biopharmaceutical company's stock after purchasing an additional 175,118 sDecember 24, 2024 | marketbeat.comHighTower Advisors LLC Reduces Stock Position in Dynavax Technologies Co. (NASDAQ:DVAX)HighTower Advisors LLC lessened its position in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 54.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 39,018 shares of the biopharmaceutical company's stock after sellingDecember 22, 2024 | marketbeat.comWellington Management Group LLP Takes $758,000 Position in Dynavax Technologies Co. (NASDAQ:DVAX)Wellington Management Group LLP purchased a new position in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 68,024 shares of the biopharmaceutiDecember 20, 2024 | marketbeat.comJane Street Group LLC Sells 328,208 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Jane Street Group LLC lowered its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 42.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 446,185 shares of the biopharmaceutical company's stock after selling 328,208 shares duringDecember 17, 2024 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Position Lessened by State Street CorpState Street Corp decreased its stake in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 3.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,690,274 shares of the biopharmaceutical company's stockDecember 17, 2024 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Shares Sold by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 78.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 25,880 shares of the biopharmacDecember 9, 2024 | marketbeat.comBank of Montreal Can Acquires 82,449 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Bank of Montreal Can increased its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 8.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,077,081 shares of the biopharmaDecember 2, 2024 | marketbeat.comGreat Point Partners LLC Reduces Holdings in Dynavax Technologies Co. (NASDAQ:DVAX)Great Point Partners LLC cut its stake in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 44.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,326,234 shares of the biopharmaceutical comNovember 27, 2024 | marketbeat.comDynavax to Present at the 7th Annual Evercore HealthCONx ConferenceNovember 26, 2024 | prnewswire.comDo Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?November 26, 2024 | msn.comPrincipal Financial Group Inc. Sells 184,961 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Principal Financial Group Inc. reduced its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 24.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 577,727 shares of the bioNovember 21, 2024 | marketbeat.comDynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To ExplodeNovember 19, 2024 | msn.comMizuho Markets Americas LLC Increases Stock Holdings in Dynavax Technologies Co. (NASDAQ:DVAX)Mizuho Markets Americas LLC boosted its holdings in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 17.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,379,582 shares of the biopharmaceutical company's stock after pNovember 16, 2024 | marketbeat.comEntropy Technologies LP Takes Position in Dynavax Technologies Co. (NASDAQ:DVAX)Entropy Technologies LP purchased a new stake in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 41,500 shares of the biopharmaceutical company's stock, valued at approximately $462,00November 16, 2024 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Stock Price Down 7.8% - Here's What HappenedDynavax Technologies (NASDAQ:DVAX) Trading Down 7.8% - Here's What HappenedNovember 15, 2024 | marketbeat.comDynavax Technologies: What The Stock Buyback Means. What It Doesn'tNovember 13, 2024 | seekingalpha.comDynavax Technologies Sets $100 Million Accelerated Stock BuybackNovember 12, 2024 | marketwatch.comDynavax announces $100M accelerated share repurchase programNovember 12, 2024 | markets.businessinsider.comDynavax To Buyback $100 Mln Of SharesNovember 12, 2024 | markets.businessinsider.comDynavax Announces $100 Million Accelerated Share Repurchase ProgramNovember 11, 2024 | prnewswire.comDynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting NextNovember 11, 2024 | finance.yahoo.comHC Wainwright Has Positive Outlook for DVAX FY2024 EarningsDynavax Technologies Co. (NASDAQ:DVAX - Free Report) - Equities researchers at HC Wainwright upped their FY2024 EPS estimates for Dynavax Technologies in a research note issued on Friday, November 8th. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company will earn $0.18November 11, 2024 | marketbeat.comEquities Analysts Set Expectations for DVAX FY2024 EarningsDynavax Technologies Co. (NASDAQ:DVAX - Free Report) - Stock analysts at William Blair lifted their FY2024 earnings per share (EPS) estimates for shares of Dynavax Technologies in a research note issued on Thursday, November 7th. William Blair analyst M. Phipps now expects that the biopharmaceutiNovember 11, 2024 | marketbeat.comDynavax Technologies Reports Strong Q3 2024 ResultsNovember 10, 2024 | markets.businessinsider.comDynavax Technologies Corporation (NASDAQ:DVAX) Q3 2024 Earnings Call TranscriptNovember 10, 2024 | msn.comDynavax Technologies’ $200M Share Buyback: Potential Risks and Financial ImplicationsNovember 9, 2024 | tipranks.com Get Dynavax Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address DVAX Media Mentions By Week DVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DVAX News Sentiment▼0.470.69▲Average Medical News Sentiment DVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DVAX Articles This Week▼64▲DVAX Articles Average Week Get Dynavax Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IONS News Today ALKS News Today FOLD News Today LGND News Today GERN News Today MNKD News Today BCRX News Today CLDX News Today NVAX News Today INVA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DVAX) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynavax Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynavax Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
